Holen Sie sich die Stockscreener-App
0.891
13.82%
0.1082
Handel nachbörslich:
.86
-0.031
-3.48%
Schlusskurs vom Vortag:
$0.7828
Offen:
$0.78
24-Stunden-Volumen:
122.77K
Relative Volume:
0.33
Marktkapitalisierung:
$1.66M
Einnahmen:
$90,700
Nettoeinkommen (Verlust:
$-3.43M
KGV:
-0.5478
EPS:
-1.6266
Netto-Cashflow:
$-4.65M
1W Leistung:
+14.07%
1M Leistung:
-14.33%
6M Leistung:
-64.64%
1J Leistung:
-88.75%
1-Tages-Spanne:
$0.78
$0.891
1-Wochen-Bereich:
$0.7015
$0.891
52-Wochen-Spanne:
$0.7015
$18.36
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Firmenname
60 Degrees Pharmaceuticals Inc
Sektor
Branche
Telefon
202-327-5422
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga
SEC Form DEF 14A filed by 60 Degrees Pharmaceuticals Inc. - Quantisnow
Allovir (ALVR) Stock Experiences Significant Decline Amid Negati - GuruFocus.com
Why Is Infection Treatment Focused-60 Degrees Pharmaceuticals Stock Soaring Today? - MSN
SXTP stock plunges to 52-week low, touches $1 mark By Investing.com - Investing.com UK
Why Are 60 Degrees Pharmaceuticals Shares Up By 50% Today? - MSN
60 Degrees Pharmaceuticals Outlines Plans For Rare Tick-Borne Infection Trial Evaluating Its Malaria Drug - MSN
60 Degrees Pharmaceuticals launches Arakoda promotional pilot - TipRanks
60 Degrees Pharmaceuticals pilots ARAKODA awareness program By Investing.com - Investing.com South Africa
60 Degrees Pharmaceuticals pilots ARAKODA awareness program - Investing.com
SXTP stock plunges to 52-week low, touches 1.01 USD By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch - The Manila Times
Del Taco Leads the Value Pack with New Del's Mucho Meal$™ and the Return of Cookie Butter Shake! - The Manila Times
Form PRE 14A 60 DEGREES PHARMACEUTICA For: Oct 02 - StreetInsider.com
K-pop group Fifty Fifty off to strong start with member line-up reboot - The Straits Times
Documented Gang Member Sentenced to Life in Prison for Killing Five People - Harris County District Attorney's Office
Ultraviolette set to export F77 sports bikes to European countries - Business Upturn
Tectonic Therapeutic reports findings from Phase Ia trial of TX45 - Clinical Trials Arena
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - EIN News
Market Trading Guide: Century Textiles, Jubilant Foodworks among 5 stock recommendations for Friday - The Economic Times
Heavy Buying Alert: Multibagger IT-stock Hits Upper Circuits On September 18; Zooms 69 Per Cent From 52-Week Low! - Dalal Street Investment Journal
100 films to be made in 48 hours - IOL
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Rating Reiterated by HC Wainwright - Defense World
Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
60 degrees pharmaceuticals director buys $8,500 in stock By Investing.com - Investing.com Canada
60 degrees pharmaceuticals director buys $8,500 in stock - Investing.com India
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Trading Down 3.1% - Defense World
SXTPW60 Degrees Pharmaceuticals, Inc. Warrant Latest Stock News & Market Updates - StockTitan
60 Degrees Pharmaceuticals Announces Closing of $4 Million Private Placement - citybiz
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 - GlobeNewswire
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Yahoo Finance
60 Degrees Pharmaceuticals to raise $4M via private placement; shares fall - MSN
60 Degrees Pharmaceuticals announces private placement sale - Investing.com India
60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement - TipRanks
60 Degrees Pharmaceuticals announces private placement sale By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
60 Degrees Pharmaceuticals Inc (SXTP)’s Day in Review: Closing at 1.34, Down by -11.84 - The Dwinnex
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements - GlobeNewswire
60 Degrees Pharmaceuticals Inc Share PriceSXTP, RNS News, Articles, Quotes, & Charts (NASDAQ: SXTP) - Proactive Investors Australia
60 Degrees Pharmaceuticals Reports Doubling of Q2 2024 Revenues and Advances Clinical Trials - Proactive Investors Australia
60 Degrees Pharmaceuticals Inc’s Mixed Bag: Down -39.50% in 6 Months, Down -7.00% in 30 Days - The InvestChronicle
Market Resilience: 60 Degrees Pharmaceuticals Inc (SXTP) Finishes Strong at 1.58, Up 1.28 - The Dwinnex
60 Degrees Pharmaceuticals Inc (SXTP)’s stock price range in the last year - US Post News
Q3 2024 EPS Estimates for 60 Degrees Pharmaceuticals, Inc. Boosted by Analyst (NASDAQ:SXTP) - Defense World
60 Degrees Pharmaceuticals Second Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Stock Rating Reaffirmed by HC Wainwright - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Issues Quarterly Earnings Results - Defense World
Financial Contrast: 60 Degrees Pharmaceuticals (NASDAQ:SXTP) and Antibe Therapeutics (OTCMKTS:ATBPF) - Defense World
60 Degrees Pharmaceuticals reports doubled Q2 revenue By Investing.com - Investing.com Australia
Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.11%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):